These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
364 related items for PubMed ID: 9886436
21. Anti-perinuclear factor compared with the so called "antikeratin" antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritides. Vincent C, de Keyser F, Masson-Bessière C, Sebbag M, Veys EM, Serre G. Ann Rheum Dis; 1999 Jan; 58(1):42-8. PubMed ID: 10343539 [Abstract] [Full Text] [Related]
22. In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum. Masson-Bessière C, Sebbag M, Durieux JJ, Nogueira L, Vincent C, Girbal-Neuhauser E, Durroux R, Cantagrel A, Serre G. Clin Exp Immunol; 2000 Mar; 119(3):544-52. PubMed ID: 10691929 [Abstract] [Full Text] [Related]
25. Recognition of new citrulline-containing peptide epitopes by autoantibodies produced in vivo and in vitro by B cells of rheumatoid arthritis patients. Szarka E, Babos F, Magyar A, Huber K, Szittner Z, Papp K, Prechl J, Pozsgay J, Neer Z, Ádori M, Nagy G, Rojkovich B, Gáti T, Kelemen J, Baka Z, Brózik M, Pazár B, Poór G, Hudecz F, Sármay G. Immunology; 2014 Feb; 141(2):181-91. PubMed ID: 24116744 [Abstract] [Full Text] [Related]
26. Diagnostic value of antibodies to filaggrin in rheumatoid arthritis. Slack SL, Mannik M, Dale BA. J Rheumatol; 1998 May; 25(5):847-51. PubMed ID: 9598878 [Abstract] [Full Text] [Related]
27. Preferential deimination of keratin K1 and filaggrin during the terminal differentiation of human epidermis. Senshu T, Kan S, Ogawa H, Manabe M, Asaga H. Biochem Biophys Res Commun; 1996 Aug 23; 225(3):712-9. PubMed ID: 8780679 [Abstract] [Full Text] [Related]
28. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis. Greiner A, Plischke H, Kellner H, Gruber R. Ann N Y Acad Sci; 2005 Jun 23; 1050():295-303. PubMed ID: 16014545 [Abstract] [Full Text] [Related]
29. The use of chimeric vimentin citrullinated peptides for the diagnosis of rheumatoid arthritis. Malakoutikhah M, Gómara MJ, Gómez-Puerta JA, Sanmartí R, Haro I. J Med Chem; 2011 Nov 10; 54(21):7486-92. PubMed ID: 21981664 [Abstract] [Full Text] [Related]
30. Role of N- or C-terminal biotinylation in autoantibody recognition of citrullin containing filaggrin epitope peptides in rheumatoid arthritis. Babos F, Szarka E, Nagy G, Majer Z, Sármay G, Magyar A, Hudecz F. Bioconjug Chem; 2013 May 15; 24(5):817-27. PubMed ID: 23617702 [Abstract] [Full Text] [Related]
31. Physical Characteristics of a Citrullinated Pro-Filaggrin Epitope Recognized by Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis Sera. Trier NH, Holm BE, Slot O, Locht H, Lindegaard H, Svendsen A, Houen G. PLoS One; 2016 May 15; 11(12):e0168542. PubMed ID: 28002483 [Abstract] [Full Text] [Related]
32. Citrullination of synovial proteins in murine models of rheumatoid arthritis. Vossenaar ER, Nijenhuis S, Helsen MM, van der Heijden A, Senshu T, van den Berg WB, van Venrooij WJ, Joosten LA. Arthritis Rheum; 2003 Sep 15; 48(9):2489-500. PubMed ID: 13130468 [Abstract] [Full Text] [Related]
33. Autoantibodies to citrullinated proteins in rheumatoid arthritis: clinical performance and biochemical aspects of an RA-specific marker. Nijenhuis S, Zendman AJ, Vossenaar ER, Pruijn GJ, vanVenrooij WJ. Clin Chim Acta; 2004 Dec 15; 350(1-2):17-34. PubMed ID: 15530456 [Abstract] [Full Text] [Related]
34. Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: relevance to antifilaggrin autoantibodies. Baeten D, Peene I, Union A, Meheus L, Sebbag M, Serre G, Veys EM, De Keyser F. Arthritis Rheum; 2001 Oct 15; 44(10):2255-62. PubMed ID: 11665966 [Abstract] [Full Text] [Related]
35. Loss-of-function mutations in the filaggrin gene: no contribution to disease susceptibility, but to autoantibody formation against citrullinated peptides in early rheumatoid arthritis. Hüffmeier U, Böiers U, Lascorz J, Reis A, Burkhardt H. Ann Rheum Dis; 2008 Jan 15; 67(1):131-3. PubMed ID: 17704064 [Abstract] [Full Text] [Related]
36. Improvement in diagnosis of rheumatoid arthritis using dual indirect immunofluorescence and immunoblotting assays for antifilaggrin autoantibodies: a retrospective 3 year study. Ferraro-Peyret C, Tebib J, Desbos A, Bihannic R, Genestier C, Letroublon MC, Veber S, Benoit E, Veysseyre-Balter C, Monier JC, Fabien N. J Rheumatol; 2002 Feb 15; 29(2):276-81. PubMed ID: 11838844 [Abstract] [Full Text] [Related]
37. Synthesis of overlapping fibrin citrullinated peptides and their use for diagnosing rheumatoid arthritis. Pérez ML, Gómara MJ, Kasi D, Alonso A, Viñas O, Ercilla G, Sanmartí R, Haro I. Chem Biol Drug Des; 2006 Oct 15; 68(4):194-200. PubMed ID: 17105483 [Abstract] [Full Text] [Related]
38. Clinical significance of anti-filaggrin antibody recognizing uncitrullinated filaggrin in rheumatoid arthritis. Choi KH, Lee EB, Yoo CD, Baek HJ, Kang SW, Shin KC, Lee YJ, Kim HA, Jeon JH, Kim CW, Shin DM, Kim IG, Son YW. Exp Mol Med; 2005 Dec 31; 37(6):546-52. PubMed ID: 16391515 [Abstract] [Full Text] [Related]
39. Primary sequence, together with other factors, influence peptide deimination by peptidylarginine deiminase-4. Stensland ME, Pollmann S, Molberg Ø, Sollid LM, Fleckenstein B. Biol Chem; 2009 Feb 31; 390(2):99-107. PubMed ID: 19040354 [Abstract] [Full Text] [Related]
40. Anti-cyclic citrullinated peptide antibodies as a diagnostic test for rheumatoid arthritis and predictor of an erosive disease. Orbach H, Gilburd B, Brickman CM, Gerli R, Shoenfeld Y. Isr Med Assoc J; 2002 Nov 31; 4(11 Suppl):892-3. PubMed ID: 12455175 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]